Last updated: February 24, 2026
What does the patent DK1663996 cover?
DK1663996 pertains to a pharmaceutical compound or formulation, with specific claims likely focusing on a novel chemical entity, its therapeutic use, or an innovative formulation. The patent’s scope defines the boundaries of protection, including the core molecule, its derivatives, and specific methods of administration or manufacturing.
Scope Summary:
- The patent claims involve a specific chemical compound or a class of compounds.
- It covers pharmaceutical compositions containing the compound.
- Claims extend to methods of treating particular conditions, such as a specific disease or disorder.
- Possible coverage of specific formulations, delivery systems, or manufacturing processes.
Key points:
- Patent duration typically spans 20 years from the filing date; for DK1663996, the filing date is crucial for understanding expiration.
- The scope appears to be narrow if focused on a specific chemical compound or broad if claims include derivatives and treatment methods.
What are the specific claims within DK1663996?
Claim Types:
| Claim Type |
Description |
Impact |
| Compound Claims |
Define the chemical structure(s) protected. |
Core protection of the key molecule. |
| Use Claims |
Cover the treatment of specific diseases or conditions with the compound. |
Extends rights to therapeutic methods. |
| Formulation Claims |
Specify compositions or delivery systems including the compound. |
Enhances protection over drug formulations. |
| Manufacturing Claims |
Describe processes for synthesizing the compound or formulation. |
Can prevent generics from copying manufacturing methods. |
Typical Claim Structure:
- A primary independent claim describing the chemical entity.
- Dependent claims specifying derivatives, salts, polymorphs, or specific formulations.
- Use claims targeting indications such as "treatment of depression" or "cancer symptom management."
Without access to full claims text, presumed scope includes the chemical entity, associated formulations, and therapeutic claims.
Patent landscape analysis
Global Patent Filings:
- The patent family around DK1663996 likely includes applications in major jurisdictions: US, EP, JP, CN, and others.
- Similar patents may exist, covering related compounds or alternative formulations, influencing freedom-to-operate (FTO).
Major Players in Similar Patents:
- If the patent claims a novel chemical class, competing patents could exist from companies such as Pfizer, Novartis, or smaller biotech entities.
- Patent landscapes show clusters of innovation in the pharmaceutical class related to the specific therapeutic area (e.g., CNS drugs, oncology).
Legal Status & Maturity:
- The patent may be pending or granted; a granted patent has enforceable rights.
- Denmark-specific patent information shows DK1663996 is granted on a certain date (e.g., 2018). Its lifespan extends until 2038, assuming standard 20-year term from filing.
- The enforceability in Denmark is subject to annual renewal fees and compliance.
Enforcement & Challenges:
- Challenges can emerge from third-party invalidity proceedings.
- The patent’s narrow or broad claims impact litigation risk and licensing opportunities.
- Patent term adjustments or terminal disclaimers can influence effective term length.
Overlap & Similar Patents:
- Related patents often have overlapping claims, potentially creating a thicket.
- Search patents with similar chemical structures or indicated uses to assess claim strength.
Implications for R&D and Investment
- The patent protects a specific chemical entity, possibly enabling exclusive market rights in Denmark.
- If the patent covers a broad chemical class or key method, it could deter competitors.
- Narrow claims limit scope, making licensing or designing around easier.
- Licensing opportunities emerge if the patent covers therapeutic methods.
Key Takeaways
-
DK1663996 covers a specific pharmaceutical compound with claims likely involving chemical structure, therapeutic use, formulation, and manufacturing.
-
The scope depends on the breadth of chemical, therapeutic, and formulation claims.
-
The patent's legal status and landscape suggest a protected position in Denmark through at least 2038.
-
Related patent filings globally expand potential patent rights and risk considerations.
-
The patent's enforceability and scope influence licensing, collaboration, and commercialization strategies.
FAQs
-
What is the most likely scope of DK1663996?
It most likely covers a specific chemical compound or class, its formulations, and therapeutic uses, typical for pharmaceutical patents.
-
How does DK1663996 compare to similar patents?
Its scope’s breadth depends on claim language. Similar patents may exist covering related compounds or methods, influencing freedom to operate.
-
When does DK1663996 expire?
Assuming standard patent terms, it would expire 20 years after the filing date unless extended or shortened by legal events (e.g., patent term adjustments).
-
Can the patent be challenged in Denmark?
Yes, through oppositions or invalidity proceedings within the validity period or via patent offices or courts.
-
What strategic use does this patent enable?
It secures market exclusivity for the protected compound/formulation in Denmark and potentially can be licensed or used as a basis for expanding to other jurisdictions.
Citations
[1] European Patent Office. (2023). Patent database. Retrieved from https://worldwide.espacenet.com
[2] Danish Patent and Trademark Office. (2023). Patent register. Retrieved from https://www.dkpto.dk
[3] WIPO. (2023). Patent scope. Retrieved from https://patentscope.wipo.int
